Sandostatin lar and Cognitive disorder - a phase IV clinical study of FDA data

Summary:

Cognitive disorder is found among people who take Sandostatin lar, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Sandostatin lar and have Cognitive disorder. It is created by eHealthMe based on reports of 32,332 people who have side effects when taking Sandostatin lar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 29, 2022

32,332 people reported to have side effects when taking Sandostatin lar.
Among them, 81 people (0.25%) have Cognitive disorder.


What is Sandostatin lar?

Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 32,393 Sandostatin lar users for its effectiveness, alternative drugs and more.

What is Cognitive disorder?

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving) is found to be associated with 2,107 drugs and 1,630 conditions by eHealthMe.

Number of Sandostatin lar and Cognitive disorder reports submitted per year:

Could Sandostatin lar cause Cognitive disorder?

Time on Sandostatin lar when people have Cognitive disorder *:

  • < 1 month: 20 %
  • 1 - 6 months: 30 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 30 %
  • 2 - 5 years: 10 %
  • 5 - 10 years: 10 %
  • 10+ years: 0.0 %

Gender of people who have Cognitive disorder when taking Sandostatin lar *:

  • female: 62.96 %
  • male: 37.04 %

Age of people who have Cognitive disorder when taking Sandostatin lar *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 1.52 %
  • 40-49: 9.09 %
  • 50-59: 12.12 %
  • 60+: 77.27 %

Common drugs people take besides Sandostatin lar *:

  1. Sandostatin: 14 people, 17.28%
  2. Paracetamol: 11 people, 13.58%
  3. Anhydrous Caffeine: 11 people, 13.58%
  4. Diclofenac: 10 people, 12.35%
  5. Synthroid: 10 people, 12.35%
  6. Moduretic 5-50: 9 people, 11.11%
  7. Afinitor: 8 people, 9.88%
  8. Crestor: 7 people, 8.64%
  9. Metformin: 7 people, 8.64%
  10. Asa: 6 people, 7.41%

Common side effects people have besides Cognitive disorder *:

  1. Memory Loss: 41 people, 50.62%
  2. Weight Decreased: 39 people, 48.15%
  3. Fatigue (feeling of tiredness): 35 people, 43.21%
  4. Pain: 34 people, 41.98%
  5. Weakness: 30 people, 37.04%
  6. Malaise (a feeling of general discomfort or uneasiness): 29 people, 35.80%
  7. Confusional State: 28 people, 34.57%
  8. Fall: 27 people, 33.33%
  9. Dizziness: 26 people, 32.10%
  10. High Blood Pressure: 26 people, 32.10%

Common conditions people have *:

  1. High Blood Pressure: 22 people, 27.16%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 18 people, 22.22%
  3. Pain: 16 people, 19.75%
  4. Carcinoid Tumor: 15 people, 18.52%
  5. Headache (pain in head): 15 people, 18.52%
  6. Sleep Disorder: 14 people, 17.28%
  7. Neuroendocrine Tumor: 13 people, 16.05%
  8. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 11 people, 13.58%
  9. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 11 people, 13.58%
  10. Muscle Aches (muscle pain): 10 people, 12.35%

* Approximation only. Some reports may have incomplete information.

Do you take Sandostatin lar and have Cognitive disorder?

Check whether Cognitive disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Sandostatin lar:

Cognitive disorder treatments and more:

COVID vaccines that are related to Cognitive disorder:

How severe was Cognitive disorder and when was it recovered:

Expand to all the drugs that have ingredients of octreotide acetate:

Common drugs associated with Cognitive disorder:

All the drugs that are associated with Cognitive disorder:

Common conditions associated with Cognitive disorder:

All the conditions that are associated with Cognitive disorder:

How the study uses the data?

The study uses data from the FDA. It is based on octreotide acetate (the active ingredients of Sandostatin lar) and Sandostatin lar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: